Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Jean Galtier (1) , Louis Drevon (2) , Yannick Le Bris (3) , Stephane Giraudier (2) , Mathieu Wemeau , Laurence Legros (4) , Damien Luque Paz (5) , François Girodon (6) , Jean-Jacques Kiladjian (2) , Charles Mesguich (1) , Marie Parrens (1) , Clémence Mediavilla (1) , Lydia Roy (7) , Alexandre Guy (1) , Olivier Mansier (8) , Jean-Christophe Ianotto , Chloe James (8)

1 CHU de Bordeaux Pellegrin [Bordeaux]
2 AP-HP - Hopital Saint-Louis [AP-HP]
3 CHU Nantes - Centre Hospitalier Universitaire de Nantes = Nantes University Hospital
4 Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
5 CHU Angers - Centre Hospitalier Universitaire d'Angers
6 CHU Dijon - Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand
7 Hôpital Henri Mondor
8 Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases

Not available.

Domains: Human health and pathology

Jean Galtier, Louis Drevon, Yannick Le Bris, Stephane Giraudier, Mathieu Wemeau, et al.. Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.. Haematologica, 2024, ⟨10.3324/haematol.2023.284488⟩. ⟨hal-04520499⟩